A Test of Neural Inertia in Humans With Xenon

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2021

Conditions

Neurocognitive Dysfunction

Interventions

DRUG

Xenon

drug given in concentrations of 0% to 60% over period of 2 hours

Trial Locations (1)

University of Pennsylvania, Perelman School of Medicine, Philadelphia

All Listed Sponsors

lead

University of Pennsylvania

OTHER

NCT02768727 - A Test of Neural Inertia in Humans With Xenon | Biotech Hunter | Biotech Hunter